Literature DB >> 8063687

In situ arterial and brain tissue PCO2 responses to acetazolamide in cats.

K Kohshi1, N Konda, Y Kinoshita, E Tsuru, A Yokota.   

Abstract

We have studied how in situ arterial (PaCO2) and brain tissue PCO2 (PbCO2) responses to acetazolamide (AZ) are affected by respiratory patterns. Sixteen cats were anesthetized with ketamine. Group 1 cats (n = 7) breathed air spontaneously. Group 2 cats (n = 6) were paralyzed and ventilated mechanically to maintain PaCO2 at 37 +/- 1 Torr before AZ administration; the respiratory rate and depth did not change during the course of measurements. Two CO2 sensors to measure in situ PaCO2 and PbCO2 continuously were used. One was placed through a burr hole into the cerebral white matter 15 mm in depth, and another was inserted into the femoral artery. After intravenous administration of AZ (20 mg/kg), PaCO2 decreased, after a significant transient rise, and then returned gradually to the baseline in group 1, but it increased gradually and reached a new steady state in group 2. PbCO2 and the PbCO2-PaCO2 gradient increased remarkably in the two groups immediately after administration. We conclude that AZ resulted in a large increase in both PbCO2 and the PbCO2-PaCO2 gradient and that there are two distinct in situ PaCO2 responses to AZ in spontaneously breathing vs. mechanically ventilated animals. The mechanisms for these observations are discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8063687     DOI: 10.1152/jappl.1994.76.5.2199

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  2 in total

1.  Acetazolamide in vestibular migraine prophylaxis: a retrospective study.

Authors:  Neşe Çelebisoy; Figen Gökçay; Ceyda Karahan; Cem Bilgen; Tayfun Kirazlı; Hale Karapolat; Timur Köse
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-01-04       Impact factor: 2.503

2.  Compromised hemodynamic response in amyloid precursor protein transgenic mice.

Authors:  Thomas Mueggler; Christine Sturchler-Pierrat; Diana Baumann; Martin Rausch; Matthias Staufenbiel; Markus Rudin
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.